Associations between fibroblast growth factor 23 and cardiovascular disease in children and adolescents: a systematic review and meta-analysis

Key Points

• Fibroblast growth factor 23 shows an association with cardiovascular disease in children and adolescents, indicating a potential health risk.
• Findings from the meta-analysis highlight that elevated levels of fibroblast growth factor 23 are linked to cardiovascular conditions.
• Systematic review of literature gathered data from various studies, contributing to a comprehensive understanding of this relationship.
• Implications underscore the importance of monitoring fibroblast growth factor 23 in younger populations to prevent cardiovascular issues.